NCT00999193

Brief Summary

Fractures of the proximal humerus are common in elderly patients. The optimal treatment of comminuted, displaced fractures is subject to controversy, and the results of operative treatment have not been shown to be superior to conservative treatment. The aim of the study is to compare locking plate osteosynthesis versus treatment with fracture hemiarthroplasty versus conservative treatment in a randomised, controlled protocol. The results of treatment are measured at 6 weeks, 3 months, 6 months, 12 months and 24 months. Main outcome measures are Pain at rest and activity (NRSs) and functional assessment of the shoulder with Constant Score. Secondary outcome measures are Simple Shoulder test (SST), Disabilities of the Arm, Shoulder and Hand (DASH), quality of life assessment (15D), subjective patient satisfaction and costs. The study also has a cohort follow-up of the patiens who decline randomisation. The recruitment target was 90 patients, but the study recruitment was stopped due to slow recruitment (too few patients presenting with eligibile injury to the hospital) at 60 patients in November 2019.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 21, 2009

Completed
1 year until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
13.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2024

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

13.3 years

First QC Date

October 20, 2009

Last Update Submit

January 4, 2025

Conditions

Keywords

ShoulderFractureLocking PlateHemiarthroplastyConservativeComminuted Proximal Humerus Fracture

Outcome Measures

Primary Outcomes (3)

  • Pain at rest Numeric Rating Scale 0-10 (NRS)

    6 weeks, 3 mo, 6 mo, 1 year, 2 years

  • Pain in active motion NRS

    6 weeks, 3 mo, 6 mo, 1 year, 2 years

  • Constant Score

    3 mo, 6 mo, 1 year, 2 years

Secondary Outcomes (5)

  • Simple Shoulder Test (SST)

    3 mo, 6 mo, 1 year, 2 years

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    3 mo, 6 mo, 1 year, 2 years

  • Quality of life assessed with 15D

    6 weeks, 3 mo, 6 mo, 1 year, 2 years

  • Subjective satisfaction

    6 weeks, 3 mo, 6 mo, 1 year, 2 years

  • Complications

    6 weeks, 3 mo, 6 mo, 1 year, 2 years

Study Arms (3)

Conservative Treatment

ACTIVE COMPARATOR
Other: Conservative treatment

ORIF w. locking plate, no luxation

EXPERIMENTAL
Procedure: locking plate, ORIF

Hemiarthroplasty, no luxation

EXPERIMENTAL
Procedure: Hemiarthroplasty

Interventions

Open reduction of the fracture (and GH joint), internal fixation with a locking plate. Tuberculum fragments are sutured to the plate with thick non-absorbable suture.

ORIF w. locking plate, no luxation

Replacement of the humeral articular head with hemiprosthesis. Tubercles are sutured to the prosthesis with thick nonabsorbable sutures.

Hemiarthroplasty, no luxation

Immobilisation in a supporting brace for 3 weeks, then increasingly active rehabilitation program supported by a physiotherapist until 12 weeks of the injury.

Conservative Treatment

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 65 years and older
  • Acute trauma: 1. randomisation (op vs cons) within 7 days of injury.
  • or 4-part fracture with \>5mm dislocation of the anatomic neck.
  • AO classification C1-2 for non-luxation fractures
  • AO classification C3 for luxation fractures

You may not qualify if:

  • Head Splitting fracture
  • Open fracture
  • Additional fractures in the shoulder region
  • Other injuries requiring surgical treatment
  • Clinically significant injury of the brachial plexus or vasculature
  • Pathological fracture associated with cancer
  • History of a fracture of the clavicle, scapula or humerus, or history of a very significant disease or trauma of the shoulder region (hemiparesis, tumour, osteomyelitis, grave arthrosis etc)
  • Rheumatoid Arthritis in the shoulder requiring active treatment
  • Reduced co-operation or incapability for independent living (dementia, mental illness, drug- or alcohol abuse etc)
  • unwillingness to accept some of the treatment options.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Töölö Hospital Trauma Center, Helsinki University Central Hospital,

Helsinki, Finland

Location

Related Publications (1)

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

MeSH Terms

Conditions

Humeral FracturesFractures, Bone

Interventions

HemiarthroplastyConservative Treatment

Condition Hierarchy (Ancestors)

Arm InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis ImplantationTherapeutics

Study Officials

  • Tuomas Lähdeoja, MD

    University of Helsinki

    PRINCIPAL INVESTIGATOR
  • Mika Paavola, MD, PhD

    University of Helsinki

    STUDY DIRECTOR
  • Jarkko Pajarinen, MD, PhD

    University of Helsinki

    STUDY DIRECTOR
  • Seppo Koskinen, MD, PhD

    University of Helsinki

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 20, 2009

First Posted

October 21, 2009

Study Start

November 1, 2010

Primary Completion

February 22, 2024

Study Completion

February 22, 2024

Last Updated

January 7, 2025

Record last verified: 2025-01

Locations